These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33379411)

  • 1. Therapeutic Ophthalmic Lenses: A Review.
    Toffoletto N; Saramago B; Serro AP
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33379411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.
    Abdi B; Mofidfar M; Hassanpour F; Kirbas Cilingir E; Kalajahi SK; Milani PH; Ghanbarzadeh M; Fadel D; Barnett M; Ta CN; Leblanc RM; Chauhan A; Abbasi F
    Int J Pharm; 2023 May; 638():122740. PubMed ID: 36804524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
    Hsu KH; Carbia BE; Plummer C; Chauhan A
    Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update.
    Baghban R; Talebnejad MR; Meshksar A; Heydari M; Khalili MR
    J Nanobiotechnology; 2023 Nov; 21(1):402. PubMed ID: 37919748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
    Babizhayev MA
    Drug Metabol Drug Interact; 2009; 24(2-4):275-323. PubMed ID: 20408504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact lenses as drug-delivery systems: a promising therapeutic tool.
    Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting contact lenses: Progress, challenges, and prospects.
    Gao D; Yan C; Wang Y; Yang H; Liu M; Wang Y; Li C; Li C; Cheng G; Zhang L
    Biointerphases; 2024 Jul; 19(4):. PubMed ID: 38984804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
    Hsu KH; Fentzke RC; Chauhan A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact Lenses as Ophthalmic Drug Delivery Systems: A Review.
    Franco P; De Marco I
    Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact lenses as a platform for ocular drug delivery.
    Bengani LC; Hsu KH; Gause S; Chauhan A
    Expert Opin Drug Deliv; 2013 Nov; 10(11):1483-96. PubMed ID: 23875917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic contact lenses for ophthalmic drug delivery: major challenges.
    Zhang X; Cao X; Qi P
    J Biomater Sci Polym Ed; 2020 Mar; 31(4):549-560. PubMed ID: 31902299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions.
    Ioniță M; Vlăsceanu GM; Toader AG; Manole M
    J Pers Med; 2023 Nov; 13(11):. PubMed ID: 38003886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact lens as an emerging platform for ophthalmic drug delivery: A systematic review.
    Yang H; Zhao M; Xing D; Zhang J; Fang T; Zhang F; Nie Z; Liu Y; Yang L; Li J; Wang D
    Asian J Pharm Sci; 2023 Sep; 18(5):100847. PubMed ID: 37915758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Drug Delivery: Present Innovations and Future Challenges.
    Gote V; Sikder S; Sicotte J; Pal D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic contact lenses: a patent review.
    Dixon P; Shafor C; Gause S; Hsu KH; Powell KC; Chauhan A
    Expert Opin Ther Pat; 2015; 25(10):1117-29. PubMed ID: 26143943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.